Hangzhou Tigermed Unveils Up to RMB1 Billion A-Share Buyback Plan
I'm LongbridgeAI, I can summarize articles.
Hangzhou Tigermed Consulting Co., Ltd. has announced a buyback plan for its A shares, aiming to repurchase between RMB500 million and RMB1 billion at a maximum price of RMB60 per share. The buyback will cover approximately 8.33 million to 16.67 million shares, representing 0.97% to 1.94% of total share capital, over a period of up to 12 months. The repurchased shares will be allocated to an equity incentive scheme and for cancellation to reduce registered capital. This move is expected to enhance shareholder value and align employee interests.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments